BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 30, 2024 16:05 ET
|
BioSig Technologies, Inc.
Westport, CT, May 30, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and...
Celcuity Announces Pricing of Underwritten Common Stock Offering
May 30, 2024 07:36 ET
|
Celcuity Inc.
MINNEAPOLIS, May 30, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the...
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
May 23, 2024 16:01 ET
|
Genelux Corporation
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
Evergold Announces Private Placement of up to $3,500,000 to Support Follow-up Drilling at DEM Gold-Silver++ Discovery, BC
May 21, 2024 07:00 ET
|
Evergold Corp.
Evergold Announces Private Placement of up to $3,500,000 to Support Follow-up Drilling at DEM Gold-Silver++ Discovery, BC
HEPHAISTOS sécurise 10,3 M€ pour aller jusqu’en clinique
May 16, 2024 00:00 ET
|
Hephaistos Pharma
Communiqué : HEPHAISTOS sécurise 10,3 M€ pour aller jusqu’en clinique HEPHAISTOS-Pharma accueille Elaia qui boucle son tour d’amorçage, sécurisant ainsi un total de 10,3 millions d'euros, entre...
HEPHAISTOS secures €10.3 M to reach the clinical stage
May 16, 2024 00:00 ET
|
Hephaistos Pharma
PR: HEPHAISTOS secures €10.3 M to reach the clinical stage HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a total of €10.3 million from investors and non-dilutive financing. ...
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024 18:00 ET
|
Vaccinex, Inc.
Last patient last visit in SIGNAL-AD Phase 2a study of pepinemab treatment for Alzheimer’s Disease in early June 2024. $8.2 million of new financing in Q1.
Mitsubishi HC Capital America and Electrada Partner to Provide EV Charging-as-a-Service for Vehicle OEMs and Commercial Customers
May 15, 2024 08:02 ET
|
Mitsubishi HC Capital America
NORWALK, Conn., May 15, 2024 (GLOBE NEWSWIRE) -- Despite a recent growth forecast of 27.5% CAGR and the size of the electric vehicle (EV) charging infrastructure market estimated to exceed $224.8...
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
May 10, 2024 17:40 ET
|
Tevogen Bio Inc
$50 million in financing advances operational objectives and bolsters a financial path to positive cashflow with minimal dilution.
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
May 09, 2024 12:00 ET
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer